Filing Information
| Accession Number | 0001213900-26-100280 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 16, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
164,706
Total Value
$45,523.02
P&L
+inf% (+$1,257,418.80)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Science Officer | Class A Ordinary Shares | โ | Aug 20, 2026 | Grant/Award | 3,600 | $0.00 | $0.00 | 3,600 | Indirect | By Spouse | View Details | |
Chief Science Officer | Class A Ordinary Shares | โ | Sep 12, 2026 | Exercise/Conversion | 5,728 | $0.00 | $0.00 | 5,728 | Direct | โ | View Details | |
Chief Science Officer | Class A Ordinary Shares | โ | Sep 12, 2026 | Sale to Issuer | 2,991 | $15.22 | $45,523.02 | 2,737 | Direct | โ | View Details | |
Chief Science Officer | Stock Option (Right to Buy) | Derivative | Mar 19, 2026 | Grant/Award | 55,000 | โ | โ | 55,000 | Indirect | By Spouse | View Details | |
Chief Science Officer | Restricted Stock Unit | Derivative | Jun 12, 2026 | Grant/Award | 91,659 | $0.00 | $0.00 | 91,659 | Direct | โ | View Details | |
Chief Science Officer | Restricted Stock Unit | Derivative | Sep 12, 2026 | Exercise/Conversion | 5,728 | $0.00 | $0.00 | 85,931 | Direct | โ | View Details |